Advertisement

Severe Aortic Stenosis Treatment: Percutaneous Options, Patient Selection, and Preoperative Evaluation

  • Renato RazzoliniEmail author
  • Elisa Covolo
Chapter

Abstract

The implantation procedure of transcatheter aortic valve prosthesis (TAVI) was introduced in 2002 by Prof. Alain Cribier [1]. This interventional strategy has emerged as an attractive treatment superior to medical therapy alone and as the only treatment option for patients with severe symptomatic aortic valve stenosis judged inoperable with conventional surgery [2]. Furthermore, it has proven to be a viable alternative therapy for patients considered at high and intermediate surgical risk [3–5]. Conventional aortic valve replacement (AVR) however still remains the approach of choice in symptomatic patients with low-intermediate operative risk.

Keywords

Aortic Stenosis Aortic Valve Replacement Aortic Valve Stenosis Surgical Aortic Valve Replacement Heart Team 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Leon MB, Smith CR, Mack M, et al. Transcatheter aortic valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.CrossRefPubMedGoogle Scholar
  3. 3.
    Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.CrossRefPubMedGoogle Scholar
  4. 4.
    Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–20.CrossRefPubMedGoogle Scholar
  5. 5.
    Thorani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016. doi: 10.1016/S0140-6736(16)30073-3.Google Scholar
  6. 6.
    Agarwal S, Tuzcu EM, Krishnaswamy A, et al. Transcatheter aortic valve replacement: current perspectives and future implications. Heart. 2015;101:169–77.CrossRefPubMedGoogle Scholar
  7. 7.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin 3rd JP, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt 3rd TM, Thomas JD, ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the american college of cardiology/american heart association task force on practice guidelines. Circulation. 2014;129(23):2440–92.CrossRefPubMedGoogle Scholar
  8. 8.
    Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.CrossRefPubMedGoogle Scholar
  9. 9.
    Holmes Jr DR, Rich JB, Zoghbi WA, Mack MJ. The heart team of cardiovascular care. J Am Coll Cardiol. 2013;61(9):903–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson Jr TB, Grover FL, Edwards FH. The society of thoracic surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75(6):1856–64; discussion 1864–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.CrossRefPubMedGoogle Scholar
  12. 12.
    Johansson M, Nozohoor S, Zindovic I, Nilsson J, Kimblad PO, Sjögren J. Prediction of 30-day mortality after transcatheter aortic valve implantation: a comparison of logistic EuroSCORE, STS score, and EuroSCORE II. J Heart Valve Dis. 2014;23(5):567–74.PubMedGoogle Scholar
  13. 13.
    Green P, Woglom AE, Genereux P, Daneault B, Paradis JM, Schnell S, Hawkey M, Maurer MS, Kirtane AJ, Kodali S, Moses JW, Leon MB, Smith CR, Williams M. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv. 2012;5(9):974–81.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Stortecky S, Schoenenberger AW, Moser A, Kalesan B, Jüni P, Carrel T, Bischoff S, Schoenenberger CM, Stuck AE, Windecker S, Wenaweser P. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012;5(5):489–96.CrossRefPubMedGoogle Scholar
  15. 15.
    Carabello BA. Low-gradient, low-ejection fraction aortic stenosis: what we know and what we do not know. JACC Cardiovasc Interv. 2012;5:560–2.CrossRefPubMedGoogle Scholar
  16. 16.
    Tribouilloy C, Lévy F, Rusinaru D, et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol. 2009;53:1865–73.CrossRefPubMedGoogle Scholar
  17. 17.
    Gotzmann M, Lindstaedt M, Bojara W, et al. Clinical outcome of transcatheter aortic valve implantation in patients with low-flow, low gradient aortic stenosis. Catheter Cardiovasc Interv. 2012;79:693–701.CrossRefPubMedGoogle Scholar
  18. 18.
    Le Ven F, Freeman M, Webb J, et al. Impact of low flow on the outcome of high-risk patients undergoing transcatheter aortic valve replacement. J Am Coll Cardiol. 2013;62:782–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Covolo E, Saia F, Napodano M, et al. Comparison of balloon-expandable versus self-expandable valves for transcatheter aortic valve implantation in patients with low-gradient severe aortic stenosis and preserved left ventricular ejection fraction. Am J Cardiol. 2015;115(6):810–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Gasparetto V, Fraccaro C, Tarantini G, Buja P, D’Onofrio A, Yzeiraj E, Pittarello D, Isabella G, Gerosa G, Iliceto S, Napodano M. Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2013;81(2):376–83.CrossRefPubMedGoogle Scholar
  21. 21.
    Melby SJ, Moon MR, Lindman BR, Bailey MS, Hill LL, Damiano Jr RJ. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg. 2011;141:1424–30.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Dvir D, Waksman R, Barbash IM, et al. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol. 2014;63:269–79.CrossRefPubMedGoogle Scholar
  23. 23.
    Arnold SV, Reynolds MR, Lei Y, et al. Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. Circulation. 2014;129:2682–90.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Arnold SV, Spertus JA, Lei Y, et al. How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial. Circ Cardiovasc Qual Outcomes. 2013;6:591–7.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Lindman BR, Alexander KP, O’ Gara PT, et al. Futility, benefit, and transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2014;7:707–16.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Stortecky S, Schoenenberger AW, Moser A, et al. Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2012;5:489–96.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Department of Cardiological, Thoracic and Vascular Sciences, Clinical CardiologyUniversity of PadovaPadovaItaly

Personalised recommendations